keyword
MENU ▼
Read by QxMD icon Read
search

Cardiomems

keyword
https://www.readbyqxmd.com/read/28611348/early-detection-of-subclinical-aortic-valve-endocarditis-with-the-cardiomems-heart-failure-system
#1
Sinan Sarsam, Georgy Kaspar, Shukri David, Marcel Zughaib
BACKGROUND The CardioMEMS Heart Failure System is a well validated tool to optimize management of systolic and diastolic heart failure and has been shown to reduce the risk of hospitalization by 37%. We are reporting a unique case of acute aortic valve insufficiency as a first sign of endocarditis, detected early in a patient with the CardioMEMS device. CASE REPORT A 79-year-old man with dual bioprosthetic mitral and aortic valve replacement and non-ischemic cardiomyopathy had a CardioMEMS Heart Failure System implanted 2 months following valve replacement surgery...
June 14, 2017: American Journal of Case Reports
https://www.readbyqxmd.com/read/28533992/ambulatory-heart-failure-monitoring-a-systemic-review
#2
REVIEW
Muhammad A Mangi, Hiba Rehman, Muhammad Rafique, Michael Illovsky
Heart failure (HF) is one of the leading causes of morbidity and mortality and has a large effect on the country's economy. Although there have been major advances in HF monitoring, including more advanced pharmacological management and device-based therapy, HF-related mortality remains high. It is important to monitor HF so that HF-related hospitalization and mortality can be prevented. Due to the lower sensitivity of clinical features and biochemical markers, as well as the failure of telemonitoring in early detection of HF, more advanced techniques have been sought to more accurately predict impending HF, in order to address timely pharmacological management and prevent heart failure hospitalization (HFH)...
April 18, 2017: Curēus
https://www.readbyqxmd.com/read/28493849/effects-of-pressure-variation-and-atrial-fibrillation-on-cardiomems-%C3%A2-hf-measured-pulmonary-artery-diastolic-pressure-comparison-of-device-averaged-and-visually-inspected-waveforms
#3
Aaron M Wolfson, Omid Yousefian, Lindsay Short, Daniel O'Brien, Guy Talmor, Jessica Qiu, Andrew Yoon, Michael Fong, Leslie Saxon, Rahul Doshi, Luanda Grazette, David M Shavelle
OBJECTIVE: Heart failure (HF) management guided by implantable hemodynamic monitoring reduces hospitalization rates. Hemodynamic data from the CardioMEMS(™) HF system includes device-averaged pulmonary artery pressures (PAP) and heart rate. Agreement of device-averaged values compared to the standard method of visual inspection of pressure waveforms at end-expiration is unknown. We evaluated the agreement between device-averaged and visually inspected end-expiratory PAP. APPROACH: Twenty-one patients implanted with the CardioMEMS(™) HF system were evaluated...
May 11, 2017: Physiological Measurement
https://www.readbyqxmd.com/read/28377440/late-migration-of-a-cardiomems-tm-wireless-pulmonary-artery-hemodynamic-monitoring-sensor
#4
Aniket S Rali, Zubair Shah, Andrew Sauer, Kamal Gupta
No abstract text is available yet for this article.
April 2017: Circulation. Heart Failure
https://www.readbyqxmd.com/read/28272808/cost-effectiveness-of-remote-cardiac-monitoring-with-the-cardiomems-heart-failure-system
#5
Jordana K Schmier, Kevin L Ong, Gregg C Fonarow
Heart failure (HF) is a leading cause of cardiovascular mortality in the United States and presents a substantial economic burden. A recently approved implantable wireless pulmonary artery pressure remote monitor, the CardioMEMS HF System, has been shown to be effective in reducing hospitalizations among New York Heart Association (NYHA) class III HF patients. The objective of this study was to estimate the cost-effectiveness of this remote monitoring technology compared to standard of care treatment for HF...
March 8, 2017: Clinical Cardiology
https://www.readbyqxmd.com/read/28219895/impact-of-practice-based-management-of-pulmonary-artery-pressures-in-2000-patients-implanted-with-the-cardiomems-sensor
#6
J Thomas Heywood, Rita Jermyn, David Shavelle, William T Abraham, Arvind Bhimaraj, Kunjan Bhatt, Fareed Sheikh, Eric Eichorn, Sumant Lamba, Rupinder Bharmi, Rahul Agarwal, Charisma Kumar, Lynne W Stevenson
BACKGROUND: Elevated pulmonary artery (PA) pressures in patients with heart failure are associated with a high risk for hospitalization and mortality. Recent clinical trial evidence demonstrated a direct relationship between lowering remotely monitored PA pressures and heart failure hospitalization risk reduction with a novel implantable PA pressure monitoring system (CardioMEMS HF System, St. Jude Medical). This study examines PA pressure changes in the first 2000 US patients implanted in general practice use...
April 18, 2017: Circulation
https://www.readbyqxmd.com/read/28176424/the-cost-effectiveness-of-real-time-pulmonary-artery-pressure-monitoring-in-heart-failure-patients-a-european-perspective
#7
Martin R Cowie, Marcus Simon, Liviu Klein, Praveen Thokala
AIMS: Heart failure (HF) treatment guided by physicians with access to real-time pressure measurement from a wireless implantable pulmonary artery pressure (PAP) sensor (CardioMEMS), has previously been shown to reduce HF-related hospital admissions in the CHAMPION trial. However, uncertainty remains regarding the value of CardioMEMS in European health systems where healthcare costs are significantly lower than in the USA. METHODS AND RESULTS: A Markov model was developed to estimate the cost-effectiveness of PAP-guided treatment of HF using the CardioMEMS™ HF system compared with usual care...
May 2017: European Journal of Heart Failure
https://www.readbyqxmd.com/read/28163833/ambulatory-pulmonary-artery-pressure-monitoring-in-advanced-heart-failure-patients
#8
REVIEW
Srikanth Yandrapalli, Anoshia Raza, Sohaib Tariq, Wilbert S Aronow
Heart failure (HF) is an emerging epidemic associate with significant morbidity, mortality, and health care expenditure. Although there were major advances in pharmacologic and device based therapies for the management of HF, mortality of this condition remains high. Accurate monitoring of HF patients for exacerbations is very important to reduce recurrent hospitalizations and its associated complications. With the failure of clinical signs, tele-monitoring, and laboratory bio-markers to function as early markers of HF exacerbations, more sophisticated techniques were sought to accurately predict the circulatory status in HF patients in order to execute timely pharmacological intervention to reduce frequent hospitalizations...
January 26, 2017: World Journal of Cardiology
https://www.readbyqxmd.com/read/27683632/hemodynamic-monitoring-in-heart-failure-and-pulmonary-hypertension-from-analog-tracings-to-the-digital-age
#9
REVIEW
Ryan Davey, Amresh Raina
Hemodynamic monitoring has long formed the cornerstone of heart failure (HF) and pulmonary hypertension diagnosis and management. We review the long history of invasive hemodynamic monitors initially using pulmonary artery (PA) pressure catheters in the hospital setting, to evaluating the utility of a number of implantable devices that can allow for ambulatory determination of intracardiac pressures. Although the use of indwelling PA catheters has fallen out of favor in a number of settings, implantable devices have afforded clinicians an opportunity for objective determination of a patient's volume status and pulmonary pressures...
September 24, 2016: World Journal of Transplantation
https://www.readbyqxmd.com/read/27647784/pulmonary-artery-pressure-guided-heart-failure-management-us-cost-effectiveness-analyses-using-the-results-of-the-champion-clinical-trial
#10
Melissa Martinson, Rupinder Bharmi, Nirav Dalal, William T Abraham, Philip B Adamson
AIMS: Haemodynamic-guided heart failure (HF) management effectively reduces decompensation events and need for hospitalizations. The economic benefit of clinical improvement requires further study. METHODS AND RESULTS: An estimate of the cost-effectiveness of haemodynamic-guided HF management was made based on observations published in the randomized, prospective single-blinded CHAMPION trial. A comprehensive analysis was performed including healthcare utilization event rates, survival, and quality of life demonstrated in the randomized portion of the trial (18 months)...
May 2017: European Journal of Heart Failure
https://www.readbyqxmd.com/read/27599253/cardiomems-hf-for-the-management-of-heart-failure-effectiveness-and-value
#11
Daniel A Ollendorf, Alexander T Sandhu, Steven D Pearson
No abstract text is available yet for this article.
October 1, 2016: JAMA Internal Medicine
https://www.readbyqxmd.com/read/27465538/pulmonary-pressure-monitoring-for-patients-with-heart-failure
#12
REVIEW
Jennifer T Wang, William H Frishman
Heart failure (HF) affects over 5.8 million patients in the United States, and can be very costly due to the number of hospitalizations and rehospitalizations during the final years of life. Due to the large number of hospitalizations for HF exacerbations, effective methods for preventing these occurrences are necessary. Improvements in the outpatient treatment of HF, aided by noninvasive and invasive home monitoring methods, can reduce the number of hospitalizations. Pulmonary pressure monitoring through the CardioMEMS system provides one method of hemodynamic assessment of patients...
March 2017: Cardiology in Review
https://www.readbyqxmd.com/read/27342204/the-cardiomems-heart-failure-sensor-a-procedural-guide-for-implanting-physicians
#13
REVIEW
David Shavelle, Rita Jermyn
The CardioMEMS heart failure system is a recent Food and Drug Administration approved device that can be implanted in patients with New York Heart Association class III heart failure and allows remote monitoring of pulmonary artery pressures. There is limited published information regarding the implantation procedure. Successful use of the CardioMEMS heart failure system requires an understanding of the technical issues surrounding the implantation procedure. The goal of the present review is to provide a summary of the implantation procedure, discuss the required imaging steps, review procedural supplies, and present a series of case studies to illustrate clinically relevant issues that may arise during sensor implantation...
July 2016: Journal of Invasive Cardiology
https://www.readbyqxmd.com/read/27220593/pulmonary-artery-pressure-guided-heart-failure-management-reduces-30-day-readmissions
#14
Philip B Adamson, William T Abraham, Lynne Warner Stevenson, Akshay S Desai, JoAnn Lindenfeld, Robert C Bourge, Jordan Bauman
BACKGROUND: This study examines the impact of pulmonary artery pressure-guided heart failure (HF) care on 30-day readmissions in Medicare-eligible patients. METHODS AND RESULTS: The CardioMicroelectromechanical system (CardioMEMS) Heart Sensor Allows Monitoring of Pressures to Improve Outcomes in New York Heart Association Class III Heart Failure Patients (CHAMPION) Trial included 550 patients implanted with a permanent MEMS-based pressure sensor in the pulmonary artery...
June 2016: Circulation. Heart Failure
https://www.readbyqxmd.com/read/26881785/remote-heart-function-monitoring-role-of-the-cardiomems-hf-system
#15
REVIEW
Emilio Vanoli, Emilia D'Elia, Maria T La Rovere, Edoardo Gronda
Heart failure is a pandemic condition that is challenging cardiology today. The primary economical and social burden of this syndrome is hospitalization rate whose costs represent the highest ones within the entire healthcare management. Remote monitoring of physiological data, obtained through self-reporting via telephone calls or, automatically, using external devices is a potential novel approach to implement management of patients with heart failure and reduce hospitalization rates. Relatively large but, sometimes, contradicting information exists about the efficacy of remote monitoring via different noninvasive approaches to reduce the economical and social burden of heart failure management...
July 2016: Journal of Cardiovascular Medicine
https://www.readbyqxmd.com/read/26874388/interventions-linked-to-decreased-heart%C3%A2-failure-hospitalizations-during-ambulatory-pulmonary-artery-pressure%C3%A2-monitoring
#16
Maria R Costanzo, Lynne W Stevenson, Philip B Adamson, Akshay S Desai, J Thomas Heywood, Robert C Bourge, Jordan Bauman, William T Abraham
OBJECTIVES: This study sought to analyze medical therapy data from the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in Class III Heart Failure) trial to determine which interventions were linked to decreases in heart failure (HF) hospitalizations during ambulatory pulmonary artery (PA) pressure-guided management. BACKGROUND: Elevated cardiac filling pressures, which increase the risk of hospitalizations and mortality, can be detected using an ambulatory PA pressure monitoring system before onset of symptomatic congestion allowing earlier intervention to prevent HF hospitalizations...
May 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/26874380/cost-effectiveness-of-implantable-pulmonary-artery-pressure-monitoring-in%C3%A2-chronic-heart-failure
#17
Alexander T Sandhu, Jeremy D Goldhaber-Fiebert, Douglas K Owens, Mintu P Turakhia, Daniel W Kaiser, Paul A Heidenreich
OBJECTIVES: This study aimed to evaluate the cost-effectiveness of the CardioMEMS (CardioMEMS Heart Failure System, St Jude Medical Inc, Atlanta, Georgia) device in patients with chronic heart failure. BACKGROUND: The CardioMEMS device, an implantable pulmonary artery pressure monitor, was shown to reduce hospitalizations for heart failure and improve quality of life in the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients) trial...
May 2016: JACC. Heart Failure
https://www.readbyqxmd.com/read/23737229/disease-management-remote-monitoring-in-heart-failure-patients-with-implantable-defibrillators-resynchronization-devices-and-haemodynamic-monitors
#18
William T Abraham
Heart failure represents a major public health concern, associated with high rates of morbidity and mortality. A particular focus of contemporary heart failure management is reduction of hospital admission and readmission rates. While optimal medical therapy favourably impacts the natural history of the disease, devices such as cardiac resynchronization therapy devices and implantable cardioverter defibrillators have added incremental value in improving heart failure outcomes. These devices also enable remote patient monitoring via device-based diagnostics...
June 2013: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/23352783/overview-of-the-2011-food-and-drug-administration-circulatory-system-devices-panel-of-the-medical-devices-advisory-committee-meeting-on-the-cardiomems-champion-heart-failure-monitoring-system
#19
REVIEW
Joshua P Loh, Israel M Barbash, Ron Waksman
The CardioMEMS Champion Heart Failure Monitoring System (CardioMEMS, Atlanta, Georgia) is a permanently implantable pressure measurement system designed to wirelessly measure and monitor pulmonary artery (PA) pressure and heart rate in heart failure (HF) patients to guide ambulatory HF management and to reduce HF hospital stays. On December 8, 2011, the Food and Drug Administration (FDA) Circulatory System Device Panel reviewed the CardioMEMS Champion HF Monitoring System premarket approval (PMA) application...
April 16, 2013: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/22138425/modern-device-technologies
#20
REVIEW
Ian Crozier, Warren Smith
Implantable cardiac devices for arrhythmias and related conditions are a rapidly evolving field, with a constant stream of technologies being developed. There are a number of novel devices, other than conventional pacemakers and implantable defibrillators, currently being developed that have the potential to greatly improve patient outcomes. This paper reviews the important recent technologies, the subcutaneous defibrillator, cardiac contraction modulation, the HeartPOD and CardioMEMS heart failure monitors, left atrial appendage closure devices and leadless cardiac pacing...
June 2012: Heart, Lung & Circulation
keyword
keyword
25871
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"